SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-024506
Filing Date
2021-05-06
Accepted
2021-05-06 07:10:36
Documents
3
Period of Report
2021-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kymr-8k_20210331.htm 8-K 34747
2 EX-99.1 kymr-ex991_6.htm EX-99.1 187704
3 GRAPHIC gzkcxsblym1u000001.jpg GRAPHIC 4793
  Complete submission text file 0001564590-21-024506.txt   230368
Mailing Address 300 TECHNOLOGY SQUARE 2ND FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 2ND FLOOR CAMBRIDGE MA 02139 857-285-5314
Kymera Therapeutics, Inc. (Filer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39460 | Film No.: 21895751
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences